India  

Russian Direct Investment Fund

Fund established by the Russian government in June 2011

Russian Direct Investment Fund    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Russian Direct Investment Fund: Fund established by the Russian government in June 2011
The Russian Direct Investment Fund (RDIF) is Russia's sovereign wealth fund established in 2011 by the Russian government to make investments in leading companies of high-growth sectors of the Russian economy. Its mandate is to co-invest alongside the world’s largest institutional investors — direct investment funds, sovereign wealth funds and leading companies. RDIF therefore acts as a catalyst for direct investment in Russia.

0
shares
ShareTweetSavePostSend
 

You Might Like


Covid: One-dose Sputnik Light set for rollout in September

India’s immunisation plan against Covid-19 may get bolstered soon with the rollout of locally manufactured single-dose Sputnik Light in September. Panacea Biotec, which had earlier partnered Russian..
IndiaTimes - Published

Panacea Biotec to manufacture up to 25 million doses of Sputnik V vaccine

The company has entered into a "licensing and manufacturing agreement with Human Vaccine Limited Liability Company, a subsidiary of Russian Direct Investment Fund, Russia, Generium Joint Stock..
IndiaTimes - Published

Sputnik V vaccine production in India to go fully on stream in September: RDIF

The production of Sputnik V in India is expected to come fully on stream in September. "Production in India is expected to come fully onstream in September and RDIF expects India to become a major..
IndiaTimes - Published

Serum Institute to start manufacturing Sputnik vaccine in September

Serum Institute of India (SII) will start production of Sputnik vaccine at the company's facilities in September, Russian Direct Investment Fund (RDIF) said on Tuesday. "The first batch of Sputnik..
IndiaTimes - Published

Sputnik V more effective on 'Delta' Covid-19 variant than any other vaccine: RDIF


IndiaTimes - Published

Not authorised any 3rd party to supply Sputnik V in India, legal action against unscrupulous elements: Dr Reddy’s & RDIF


IndiaTimes - Published

COVID-19: Panacea Biotec, RDIF to start Sputnik V production in India

RDIF and Panacea have agreed to produce 100 million doses per year of Sputnik V.
DNA - Published

RDIF, Panacea Biotec launch production of Sputnik V vaccine in India

The Russian Direct Investment Fund (RDIF) and Indian drug firm Panacea Biotec on Monday announced the launch of production of the Sputnik V coronavirus vaccine in India. The first batch of the Covid-19..
IndiaTimes - Published

Dr Reddy's rolls out Sputnik V Covid-19 vaccine in India at around Rs 995 per dose

Dr Reddy’s Laboratories, the Indian partner of Russian Direct Investment Fund (RDIF), said it has commenced Sputnik V’s India rollout with the first dose being administered in Hyderabad on Friday..
IndiaTimes - Published

As India eyes Sputnik rollout, experts question efficacy data

Even as India is gearing up to roll out Russian Covid-19 vaccine Sputnik V next week, a group of international experts has raised serious questions about the data discrepancies and substandard..
IndiaTimes - Published

36 crore Indians to get Sputnik V COVID-19 vaccine jabs by March 2022

RDIF, which is the Russian sovereign wealth fund that has funded the vaccine, has signed pacts with 5 Indian companies to produce 850 million doses.
DNA - Published

India to receive first batch of Russia's Covid-19 vaccine on May 1: RDIF

India will receive a first batch of Russia's Sputnik V vaccine against Covid-19 on May 1, the head of the Russian Direct Investment Fund, Kirill Dmitriev, told Reuters on Monday.
IndiaTimes - Published Also reported by •DNA

RDIF expects 50 million doses a month of Sputnik V vaccine production in India


IndiaTimes - Published

India to produce 850 million Sputnik doses annually; becomes 60th country to approve the vaccine: RDIF


IndiaTimes - Published

Hyd's Virchow Biotech to make 200 million doses of Sputnik V

Russia’s sovereign wealth fund, Russian Direct Investment Fund (RDIF), has joined hands with Bengaluru-based Strides Pharma’s biopharma division Stelis Biopharma Pvt Ltd to manufacture and supply..
IndiaTimes - Published

Hyderabad’s Gland Pharma to make 252 million doses of Sputnik V

Gland Pharma, based out of Hyderabad, has entered into an agreement with Russian Direct Investment Fund (RDIF), a sovereign wealth fund, to manufacture and supply 252 million (25.2 crore) doses of the..
IndiaTimes - Published

Dr Reddy's, RDIF begin clinical trials for Russia's Sputnik V vaccine in India

Dr Reddy's and RDIF had entered into a partnership to conduct clinical trials and rights for distribution of the first 100 million doses in India.
DNA - Published

Sputnik’s ‘efficacy at 95%’, to be cheaper than US vaccines

Russia’s Sputnik V Covid-19 vaccine, that reported an efficacy of over 95%, will be twice as cheap as those by Pfizer and Moderna with similar positive results. Sputnik V, developed by Gamaleya..
IndiaTimes - Published

Dr Reddy's gets DCGI go-ahead to conduct Phase 2/3 human trials of Sputnik V in India

After the Indian drug regulator turned down Dr. Reddy’s Laboratories Ltd’s proposal earlier this month to conduct direct Phase-3 human trials for the Russian Covid-19 vaccine Sputnik V, the company..
IndiaTimes - Published

Russia, Dr Reddy’s tie up for Sputnik V trial

Russia’s sovereign wealth fund – Russian Direct Investment Fund (RDIF) — has partnered Hyderabad-based drug maker Dr Reddy’s Laboratories to cooperate on clinical trials and distribution of..
IndiaTimes - Published

Clinical trials of Sputnik V coronavirus vaccine to begin this month in countries including India: RDIF

The clinical trials of Sputnik V vaccine for coronavirus will be held this month in several countries including India, confirmed Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF) on..
IndiaTimes - Published

Russia in talks with India, drug manufactures for production of Sputnik-V coronavirus vaccine: RDIF

Russia is in close dialogue with the Indian government and the leading drug manufactures of India regarding the localization of production of Sputnik V vaccine in India, said Kirill Dmitriev, CEO of..
IndiaTimes - Published

Russia seeks collaboration with India for manufacturing Covid-19 vaccine Sputnik V: Sources

Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology along with Russian Direct Investment Fund (RDIF). The vaccine has not been tested in phase 3 or larger..
IndiaTimes - Published

Russia claims promising signs in early trials of antiviral drug favipiravir

A candidate drug for treating the new coronavirus, favipiravir, has produced promising results in early clinical trials in Russia, according to the Russian Direct Investment Fund, which provided 150..
Reuters India - Published

Russia's top Saudi negotiators praise Falih, say shake-up won't hurt ties

Changes in the Saudi Arabia's oil industry will not affect cooperation between Moscow and Riyadh, Russia's Energy Minister Alexander Novak and Kirill Dmitriev, head of the RDIF sovereign wealth fund,..
Reuters - Published